ArcticZymes Technologies ASA (AZT.OL)
NOK 16.6
(0.91%)
NOK 16.6
(0.91%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 19.42 Million NOK | -40.89% |
| 2022 | 32.86 Million NOK | -29.15% |
| 2021 | 46.38 Million NOK | -44.2% |
| 2020 | 83.11 Million NOK | 1257.16% |
| 2019 | -7.18 Million NOK | 48.65% |
| 2018 | -13.98 Million NOK | 43.9% |
| 2017 | -24.93 Million NOK | -21.77% |
| 2016 | -20.48 Million NOK | -18.08% |
| 2015 | -17.34 Million NOK | 21.13% |
| 2014 | -21.99 Million NOK | 3.92% |
| 2013 | -22.88 Million NOK | 5.88% |
| 2012 | -24.31 Million NOK | -20.97% |
| 2011 | -20.1 Million NOK | 29.56% |
| 2010 | -28.54 Million NOK | 71.28% |
| 2009 | -99.37 Million NOK | -90.44% |
| 2008 | -52.17 Million NOK | -179.56% |
| 2007 | -18.66 Million NOK | 29.97% |
| 2006 | -26.65 Million NOK | -72.56% |
| 2005 | -15.44 Million NOK | -464.69% |
| 2004 | -2.73 Million NOK | 72.19% |
| 2003 | -9.83 Million NOK | -1430.91% |
| 2002 | -642.52 Thousand NOK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 3.16 Million NOK | 57.11% |
| 2024 Q2 | 2.67 Million NOK | -15.71% |
| 2023 Q2 | 5.6 Million NOK | 11.21% |
| 2023 Q1 | 5.03 Million NOK | 529.09% |
| 2023 Q4 | 2.01 Million NOK | -66.72% |
| 2023 FY | 19.42 Million NOK | -40.89% |
| 2023 Q3 | 6.06 Million NOK | 8.15% |
| 2022 Q1 | 20.81 Million NOK | 34.84% |
| 2022 Q2 | 8.75 Million NOK | -57.96% |
| 2022 FY | 32.86 Million NOK | -29.15% |
| 2022 Q3 | 2.49 Million NOK | -71.52% |
| 2022 Q4 | 801 Thousand NOK | -67.86% |
| 2021 Q3 | 6.88 Million NOK | 46.45% |
| 2021 Q2 | 4.7 Million NOK | -75.71% |
| 2021 FY | 46.38 Million NOK | -44.2% |
| 2021 Q1 | 19.35 Million NOK | -44.05% |
| 2021 Q4 | 15.43 Million NOK | 124.18% |
| 2020 FY | 83.11 Million NOK | 1257.16% |
| 2020 Q4 | 34.59 Million NOK | 280.44% |
| 2020 Q3 | 9.09 Million NOK | -64.6% |
| 2020 Q2 | 25.68 Million NOK | 86.9% |
| 2020 Q1 | 13.74 Million NOK | 1141.55% |
| 2019 Q1 | -5.29 Million NOK | -150.64% |
| 2019 FY | -7.18 Million NOK | 48.65% |
| 2019 Q4 | 1.1 Million NOK | 493.95% |
| 2019 Q3 | -281 Thousand NOK | 85.37% |
| 2019 Q2 | -1.92 Million NOK | 63.69% |
| 2018 FY | -13.98 Million NOK | 43.9% |
| 2018 Q1 | -6.43 Million NOK | 17.57% |
| 2018 Q4 | -2.11 Million NOK | -212.74% |
| 2018 Q3 | -675 Thousand NOK | 85.84% |
| 2018 Q2 | -4.76 Million NOK | 25.94% |
| 2017 Q3 | -7.93 Million NOK | -68.59% |
| 2017 Q2 | -4.7 Million NOK | -4.83% |
| 2017 Q1 | -4.48 Million NOK | 46.47% |
| 2017 FY | -24.93 Million NOK | -21.77% |
| 2017 Q4 | -7.8 Million NOK | 1.58% |
| 2016 Q4 | -8.38 Million NOK | -35.17% |
| 2016 Q3 | -6.2 Million NOK | -197.98% |
| 2016 Q1 | -3.81 Million NOK | 53.05% |
| 2016 Q2 | -2.08 Million NOK | 45.35% |
| 2016 FY | -20.48 Million NOK | -18.08% |
| 2015 Q2 | -1.29 Million NOK | 59.68% |
| 2015 FY | -17.34 Million NOK | 21.13% |
| 2015 Q4 | -8.11 Million NOK | -72.22% |
| 2015 Q1 | -3.21 Million NOK | 44.24% |
| 2015 Q3 | -4.71 Million NOK | -263.02% |
| 2014 Q4 | -5.77 Million NOK | 6.84% |
| 2014 FY | -21.99 Million NOK | 3.92% |
| 2014 Q3 | -6.19 Million NOK | -151.81% |
| 2014 Q2 | -2.46 Million NOK | 67.45% |
| 2014 Q1 | -7.56 Million NOK | -13.58% |
| 2013 Q3 | -4.77 Million NOK | 2.49% |
| 2013 Q4 | -6.65 Million NOK | -39.41% |
| 2013 FY | -22.88 Million NOK | 5.88% |
| 2013 Q1 | -6.56 Million NOK | 4.61% |
| 2013 Q2 | -4.89 Million NOK | 25.35% |
| 2012 Q1 | -4.75 Million NOK | 28.14% |
| 2012 Q4 | -6.87 Million NOK | -0.6% |
| 2012 Q3 | -6.83 Million NOK | -16.81% |
| 2012 FY | -24.31 Million NOK | -20.97% |
| 2012 Q2 | -5.85 Million NOK | -23.12% |
| 2011 Q4 | -6.61 Million NOK | -23.14% |
| 2011 Q1 | -3.03 Million NOK | -53.38% |
| 2011 Q2 | -5.08 Million NOK | -67.3% |
| 2011 Q3 | -5.37 Million NOK | -5.71% |
| 2011 FY | -20.1 Million NOK | 29.56% |
| 2010 Q4 | -1.98 Million NOK | 74.94% |
| 2010 Q2 | -5.79 Million NOK | 54.86% |
| 2010 Q1 | -12.84 Million NOK | 0.0% |
| 2010 Q3 | -7.9 Million NOK | -36.23% |
| 2010 FY | -28.54 Million NOK | 71.28% |
| 2009 FY | -99.37 Million NOK | -90.44% |
| 2008 FY | -52.17 Million NOK | -179.56% |
| 2007 FY | -18.66 Million NOK | 29.97% |
| 2006 FY | -26.65 Million NOK | -72.56% |
| 2005 FY | -15.44 Million NOK | -464.69% |
| 2004 FY | -2.73 Million NOK | 72.19% |
| 2003 FY | -9.83 Million NOK | -1430.91% |
| 2002 FY | -642.52 Thousand NOK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Arctic Bioscience AS | -45.51 Million NOK | 142.679% |
| Aqua Bio Technology ASA | -19.11 Million NOK | 201.634% |
| BerGenBio ASA | -190.4 Million NOK | 110.202% |
| Hofseth BioCare ASA | -106.68 Million NOK | 118.208% |
| PCI Biotech Holding ASA | -20.31 Million NOK | 195.619% |
| Thor Medical ASA | -26.56 Million NOK | 173.134% |
| Ultimovacs ASA | -189.23 Million NOK | 110.265% |